AGL 7.14 Increased By ▲ 0.11 (1.56%)
ANL 10.72 Decreased By ▼ -0.03 (-0.28%)
AVN 76.80 Decreased By ▼ -0.50 (-0.65%)
BOP 5.51 Increased By ▲ 0.02 (0.36%)
CNERGY 5.27 Increased By ▲ 0.01 (0.19%)
EFERT 88.65 Increased By ▲ 0.15 (0.17%)
EPCL 74.70 Decreased By ▼ -0.20 (-0.27%)
FCCL 13.60 Decreased By ▼ -0.05 (-0.37%)
FFL 6.65 Increased By ▲ 0.03 (0.45%)
FLYNG 7.19 No Change ▼ 0.00 (0%)
GGGL 10.91 Increased By ▲ 0.01 (0.09%)
GGL 16.60 Increased By ▲ 0.08 (0.48%)
GTECH 8.69 No Change ▼ 0.00 (0%)
HUMNL 6.92 Decreased By ▼ -0.02 (-0.29%)
KEL 2.87 Increased By ▲ 0.01 (0.35%)
LOTCHEM 25.83 Increased By ▲ 0.58 (2.3%)
MLCF 25.80 Increased By ▲ 0.01 (0.04%)
OGDC 77.50 Increased By ▲ 0.10 (0.13%)
PAEL 15.53 Decreased By ▼ -0.09 (-0.58%)
PIBTL 6.04 Increased By ▲ 0.06 (1%)
PRL 16.97 Decreased By ▼ -0.22 (-1.28%)
SILK 1.26 No Change ▼ 0.00 (0%)
TELE 10.75 No Change ▼ 0.00 (0%)
TPL 9.15 Increased By ▲ 0.05 (0.55%)
TPLP 19.88 Increased By ▲ 0.03 (0.15%)
TREET 28.69 Decreased By ▼ -0.09 (-0.31%)
TRG 77.15 Increased By ▲ 0.14 (0.18%)
UNITY 19.94 No Change ▼ 0.00 (0%)
WAVES 12.60 Decreased By ▼ -0.05 (-0.4%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 4,078 Increased By 6 (0.15%)
BR30 14,906 Increased By 15.7 (0.11%)
KSE100 41,210 Increased By 50.1 (0.12%)
KSE30 15,672 Increased By 11.6 (0.07%)

BERLIN: Germany’s health minister urged the European Union on Tuesday to back a fourth COVID-19 shot for people over the age of 60 years to boost immunity in the absence of vaccines that specifically protect against the Omicron variant.

Pointing to data from Israel, minister Karl Lauterbach said a recommendation was “urgently necessary” to reduce the risk of death from an infection.

He raised the issue at a meeting of health ministers in Brussels on Tuesday and said most of them supported the idea of harmonising European vaccination strategies.

“Now the EU Commission will draw up a recommendation on the fourth vaccination within a very short time on the basis of scientific expertise,” Lauterbach told Reuters.

“Current data from Israel show: those over 60 years of age or suffering from pre-existing conditions should be vaccinated a fourth time,” he added.

EU regulator the European Medicines Agency (EMA) said on March 17 that there was not yet enough data to support a recommendation on the need for a second booster shot in the general population, while acknowledging that some member states had started such a campaign targeting the elderly.

EMA added at the time that it was hoping for more data to guide a review later in the spring.

A study from Israel showed on Sunday that senior citizens who received a second booster of the Pfizer–BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who had only one.

Earlier public health studies from Israeli had guided a decision by Germany in February to give a fourth shot to people aged 70 and older and to those at risk of severe disease.

Lauterbach said the booster strategy was urgent because he did not expect a vaccine adapted for new variants to become available before the autumn.

September is the month set for the launch of a shot that targets the dominant Omicron lineage, he said on Tuesday, but action was needed before then.

EMA’s leading vaccine expert said on March 17 he expected to receive trial data on COVID-19 vaccines tailored for the Omicron variant between April and the start of July.

Comments

Comments are closed.